# CORCEPT THERAPEUTICS INC (CORT) FY2026 Q2 Statement of Cash Flows

- Company: CORCEPT THERAPEUTICS INC (CORT)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0001628280-26-050613
- Page: https://plicit.ai/financials/cort/fy2026-q2-cash-flow
- Chart image: https://plicit.ai/charts/cort-fy2026-q2-cash-flow-sankey.png

## Chart details

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Mar 31, 2026**: 109,988,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: 33,543,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Accrued research and development expenses), so Accrued research and development expenses cannot be separated for this quarter. It may combine inflows and outflows.
- **Accretion of marketable securities, net**: negative 707,000 US dollars
- **Inventory**: negative 4,264,000 US dollars
- **Accounts payable**: negative 18,241,000 US dollars
- **Deferred income taxes**: 2,881,000 US dollars
- **Stock-based compensation**: 29,416,000 US dollars
- **Depreciation and amortization**: 863,000 US dollars
- **Accrued and other liabilities, current and non-current**: 34,315,000 US dollars
- **Net income**: 42,987,000 US dollars
- **Trade receivables**: negative 37,848,000 US dollars
- **Prepaid expenses and other current assets**: negative 3,396,000 US dollars
- **Remaining operating cash flows, net (calculated)**: negative 12,463,000 US dollars
- **Investing activities**: negative 29,242,000 US dollars. Net cash used.
- **Purchases of property and equipment**: negative 2,528,000 US dollars
- **Proceeds from sales and maturities of marketable securities**: 62,241,000 US dollars
- **Purchases of marketable securities**: negative 88,955,000 US dollars
- **Financing activities**: negative 2,037,000 US dollars. Net cash used.
- **Proceeds from purchases under the Employee Stock Purchase Program**: 3,663,000 US dollars
- **Repurchases of common stock in connection with Stock Repurchase Program**: 0 US dollars
- **Cash paid to satisfy statutory withholding requirement for net settlement of cashless option exercises and vesting of restricted stock grants**: negative 11,457,000 US dollars
- **Proceeds from stock option exercises, net of issuance costs**: 5,757,000 US dollars
- **Operating adjustment reconciliation**: 76,919,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- **financing gross reconciliation**: 11,457,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 91,483,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 37,000 US dollars
- **Ending cash on Jun 30, 2026**: 112,289,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 143,568,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 2,301,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: 0.78×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: 33,543,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 2,528,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: 31,015,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income exceeds operating cash. The diagram allocates $33.54M of net income directly to operating cash and $9.44M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 33,543,000 US dollars minus 2,528,000 US dollars equals 31,015,000 US dollars.